Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-05-09
2006-05-09
Chan, Christina (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S389200, C530S388240, C530S391100
Reexamination Certificate
active
07041803
ABSTRACT:
The present invention relates to novel galectin 11 proteins which are members of the galectin superfamily. In particular, isolated nucleic acid molecules are provided encoding the human galectin 11 proteins. Galectin 11 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of galectin 11 activity. Also provided are diagnostic and therapeutic methods.
REFERENCES:
patent: 5011912 (1991-04-01), Hopp et al.
patent: 6168920 (2001-01-01), Hillman et al.
patent: 196 49 207 (1998-02-01), None
patent: 11-46765 (1999-02-01), None
patent: WO-97/33993 (1997-09-01), None
patent: WO-98/17687 (1998-04-01), None
patent: WO-98/31799 (1998-07-01), None
patent: WO-98/50546 (1998-11-01), None
patent: WO-98/51706 (1998-11-01), None
patent: WO-98/55508 (1998-12-01), None
patent: WO-00/01728 (2000-01-01), None
patent: WO-00/09690 (2000-02-01), None
patent: WO-00/23572 (2000-04-01), None
patent: WO-00/63221 (2000-10-01), None
Lederman S, et al. A single amino acid substitution in a common African allele of the CD4 molecule ablates binding of the monoclonal antibody, OKT4. Mol Immunol. 28(11):1171-81, 1991.
Li CH, Yamashiro D, Tseng LF, Chang WC, Ferrara P. beta-Endorphin omission analogs: dissociation of immunoreactivity from other biological activities. Proc Natl Acad Sci U S A. 77(6):3211-3214, 1980.
Colman PM. Effects of amino acid sequence changes on antibody-antigen interactions. Res Immunol. 145(1):33-36, 1994.
Adams, et al., “Complementary DNA sequencing: expressed sequence tags and human genome project,”Science, 252(5013):1651-1656 (1991).
Adams, et al., “Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence,”Nature, 377(6547 Suppl):3-174 (Sep. 28, 1995).
Attwood,Science, 290:471-473 (2000).
Barondes, et al., “Galectins: a family of animal beta-galactoside-binding lectins,”Cell, 76:597-598 (1994).
Bendayan,J. Histochem. Cytochem., 43:881-886 (1995).
Bost, et al.,Immunol. Invest., 17:577-586 (1988).
Cai, et al., “An effective method for coupling single-mode fiber to thin-film waveguide,”J. of Lightwave Tech., 5:577-583 (1991).
Crocker, et al., “Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin-like domains,”EMBO J., 13(19):4490-4503 (1994).
Genbank Accession No. T48852, Hillier, et al. (Feb. 8, 1995).
Eugchi,Intern. Med., 40:275-284 (2001).
Genbank Accession No. G14442, Myers, et al. (Jan. 4, 1996).
Genbank Accession No. U71382, Patel, et al. (Nov. 12, 1996).
Genbank Accession No. AA344713, Adams, et al. (Apr. 21, 1997).
Genbank Accession No. G22008, Hudson, et al. (May 31, 1996).
Genbank Accession No. B05004, Evans, et al. (Jun. 26, 1996).
Genbank Accession No. R59292, Hillier, et al. (May 24, 1995).
Genbank Accession No. AA33451, Adams, et al. (Apr. 21, 1997).
Genbank Accession No. AA31108, Adams, et al. (Apr. 19, 1997).
Genbank Accession No. H30148, Hillier, et al. (Aug. 16, 1995).
Genbank Accession No. R59291, Hillier, et al. (May 24, 1995).
Genbank Accession No. H27468, Hillier, et al. (Aug. 16, 1995).
Genbank Accession No. AA349100, Hillier, et al. (Apr. 21, 1997).
Genbank Accession No. AA020729, Hillier, et al. (Jan. 30, 1997).
Genbank Accession No. AA001029, Hillier, et al. (Nov. 29, 1996).
Genbank Accession No. AF222695, Yang, et al. (Feb. 16, 2000).
Genbank Accession No. AF222694, Yang, et al. (Feb. 16, 2000).
Genbank Accession No. U73641, Evans, et al. (Jul. 25, 1997).
Genbank Accession No. AW075917, National Cancer Institute, et al. (Oct. 13, 1999).
Genbank Accession No. H50946, Hillier, et al. (Sep. 18, 1995).
Gitt, et al., “Sequence and mapping of galectin-5, a beta-galectosidase-binding lectin, found in rat erythrocytes,”Journal of Biological Chem., 270(10):5032-5038 (1995).
Hiller, et al., “Generation and analysis of 280,000 human expressed sequence tags,”Genome Res., 6(9):807-828 (1996) abstract only.
Hotta, et al., “Galectin-12, an adipose-expressed Galectin-like molecule possessing apoptosis-inducing activity,”J. Biol. Chem., 276(36):34089-34097 (Sep. 7, 2001).
Kelm, et al., “The Sialoadhesins: a family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily,”Glycoconj. J., 13(6):913-926 (1996).
Levi, et al., “Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits,”Eur. J. Immunol., 13:500-507 (1983).
Meikratz, et al., “Apoptosis and the cell cycle,”J. of Cell. Biochem., 58:160-174 (1995).
Metzler, et al.,Nature Structural Biol., 4:527-531 (1997).
Mountz, et al.,Curr. Rheumatol. Rep., 3:70-78 (2001).
Offner, et al., “Recombinant human beta-galactoside binding tectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis,”J. Neuroimmunology, 28:177-184 (1990).
Perillo, et al., “Apoptosis of T cells mediated by galectin-1,”Nature,378:736-739 (1995).
Rose, et al.,Brit. J. Rheumatol., 36:158-163 (1997).
Simmons, et al., “Isolation of a cDNA encoding CD33, a differentiation antigen of myeloid progenitor cells,”J. Immunology,141(8):2797-2800 (1988).
Skolnick, et al.,Trends in Biotech., 18(1):34-39 (2000).
Su, et al., “Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family,”PNAS, 93:7252-7257 (1996).
Takei, et al., “Molecular cloning of a novel gene similar to myeloid antigen DC33 and its specific expression in placenta,”Cytogenet. Cell Genet., 78:295-300 (1997).
Yang, et al., “Cell cycle regulation by Galectin-12, a new member of the Galectin superfamily,”J. Biol. Chem., 276(23):20252-20260 (Jun. 8, 2001).
Yonish-Rouach, “The p53 tumour suppressor gene: a mediator of a G1 growth arrest and of apoptosis,”Experentia, 52(10-11):1001-1007 (1996).
Zannettino, et al., “A powerful technique for isolating genes encoding surface antigens using retroviral expression cloning,”J. Immunol., 156(2):611-620 (1996).
Gentz Reiner L.
Ni Jian
Rosen Craig A.
Chan Christina
Haddad Maher
Human Genome Sciences Inc.
Human Genome Sciences Inc.
LandOfFree
Galectin 11 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Galectin 11, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galectin 11 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3643516